The groundbreaking success of Viagra undeniably transformed the drug landscape, but betting in companies strongly reliant on off-patent versions presents a challenging picture. While early returns were significant, the end of patents and the emergence of discounted alternatives have eroded sales. Thus, a thorough evaluation of present income source